Amelie Pielen1,2, Stefanie Pantenburg3, Claudia Schmoor4, Martin Schumacher5, Nicolas Feltgen3, Bernd Junker6,7, Josep Callizo3. 1. University Medical Center Freiburg, University Eye Hospital, Freiburg, Germany. Pielen.Amelie@mh-hannover.de. 2. Hannover Medical School, University Eye Hospital, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. Pielen.Amelie@mh-hannover.de. 3. University Hospital Göttingen, University Eye Hospital, Göttingen, Germany. 4. University Medical Center Freiburg, Clinical Trials Unit, Freiburg, Germany. 5. University Medical Center Freiburg, Neuroradiology, Freiburg, Germany. 6. University Medical Center Freiburg, University Eye Hospital, Freiburg, Germany. 7. Hannover Medical School, University Eye Hospital, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Abstract
INTRODUCTION: The study analyses patients' risk factors to determine prognostic and predictive factors in patients with acute central retinal artery occlusion (CRAO) treated in the randomized European Assessment Group for Lysis in the Eye (EAGLE) Study with local intra-arterial fibrinolysis (LIF) or conservative standard treatment (CST). These data could improve patient selection for either method. METHODS: Post hoc statistical analysis of effects of risk factors on overall best corrected visual acuity (BCVA [logarithm of the minimum angle of resolution (logMAR)]) at baseline and month 1 (prognostic effect) and on the difference between outcome of CST and LIF (predictive effect) was conducted. RESULTS:Seventy two of 84 EAGLE datasets were included. Prognostic effect: Patients with coronary heart disease (CHD) presented worse BCVA at baseline (0.39 logMAR, p = 0.0097). Patients with time from occlusion to treatment <12 h showed a trend to better vision gain at month 1 (-0.23 logMAR, p = 0.086), similarly smoking (-0.24 logMAR, p = 0.077). Predictive effect: Age (<60 years favours LIF -0.54 logMAR; >70 years favours CST 0.28 logMAR; interaction p = 0.070) and CHD (favours CST0.44 logMAR; interaction p = 0.073) might be predictors of therapeutic outcome. There were no strong effects in multivariate analysis. CONCLUSION:CHD, time from occlusion to treatment and smoking influence BCVA at baseline and at month 1 (prognostic effect). Patients treated within 12 h are more likely to profit from treatment. In multivariate analysis, there is no clear trend to benefit from LIF even in patients with young age, no CHD and early treatment. Based on this preliminary report on a rather small sample size, we do not recommend LIF in CRAO patients.
RCT Entities:
INTRODUCTION: The study analyses patients' risk factors to determine prognostic and predictive factors in patients with acute central retinal artery occlusion (CRAO) treated in the randomized European Assessment Group for Lysis in the Eye (EAGLE) Study with local intra-arterial fibrinolysis (LIF) or conservative standard treatment (CST). These data could improve patient selection for either method. METHODS: Post hoc statistical analysis of effects of risk factors on overall best corrected visual acuity (BCVA [logarithm of the minimum angle of resolution (logMAR)]) at baseline and month 1 (prognostic effect) and on the difference between outcome of CST and LIF (predictive effect) was conducted. RESULTS: Seventy two of 84 EAGLE datasets were included. Prognostic effect: Patients with coronary heart disease (CHD) presented worse BCVA at baseline (0.39 logMAR, p = 0.0097). Patients with time from occlusion to treatment <12 h showed a trend to better vision gain at month 1 (-0.23 logMAR, p = 0.086), similarly smoking (-0.24 logMAR, p = 0.077). Predictive effect: Age (<60 years favours LIF -0.54 logMAR; >70 years favours CST 0.28 logMAR; interaction p = 0.070) and CHD (favours CST 0.44 logMAR; interaction p = 0.073) might be predictors of therapeutic outcome. There were no strong effects in multivariate analysis. CONCLUSION: CHD, time from occlusion to treatment and smoking influence BCVA at baseline and at month 1 (prognostic effect). Patients treated within 12 h are more likely to profit from treatment. In multivariate analysis, there is no clear trend to benefit from LIF even in patients with young age, no CHD and early treatment. Based on this preliminary report on a rather small sample size, we do not recommend LIF in CRAO patients.
Entities:
Keywords:
Central retinal artery occlusion; Local intra-arterial fibrinolysis; Recombinant tissue plasminogen activator
Authors: Felipe de Los Ríos la Rosa; Jane Khoury; Brett M Kissela; Matthew L Flaherty; Kathleen Alwell; Charles J Moomaw; Pooja Khatri; Opeolu Adeoye; Daniel Woo; Simona Ferioli; Dawn O Kleindorfer Journal: Stroke Date: 2012-03-22 Impact factor: 7.914
Authors: José E Cohen; Eyal Itshayek; Samuel Moskovici; John M Gomori; Shifra Fraifeld; Roni Eichel; Ronen R Leker Journal: J Clin Neurosci Date: 2011-01-21 Impact factor: 1.961
Authors: Ramon Luengo-Fernandez; Nicola L M Paul; Alastair M Gray; Sarah T Pendlebury; Linda M Bull; Sarah J V Welch; Fiona C Cuthbertson; Peter M Rothwell Journal: Stroke Date: 2013-08-06 Impact factor: 7.914
Authors: Teddy S Youn; Patrick Lavin; Morgan Patrylo; Joseph Schindler; Howard Kirshner; David M Greer; Matthew Schrag Journal: J Neurol Date: 2017-12-13 Impact factor: 4.849
Authors: Omar F Khan; Piotr S Kowalski; Joshua C Doloff; Jonathan K Tsosie; Vasudevan Bakthavatchalu; Caroline Bodi Winn; Jennifer Haupt; Morgan Jamiel; Robert Langer; Daniel G Anderson Journal: Sci Adv Date: 2018-06-27 Impact factor: 14.136
Authors: Ethan K Sobol; Yu Sakai; Danielle Wheelwright; Carl S Wilkins; Amanda Norchi; Michael G Fara; Christopher Kellner; James Chelnis; J Mocco; Richard B Rosen; Reade A De Leacy; Gareth M C Lema Journal: Clin Ophthalmol Date: 2021-02-16